Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Advances in minimal residual disease monitoring in multiple myeloma.
Wijnands C, Noori S, Donk NWCJV, VanDuijn MM, Jacobs JFM. Wijnands C, et al. Crit Rev Clin Lab Sci. 2023 Nov;60(7):518-534. doi: 10.1080/10408363.2023.2209652. Epub 2023 May 26. Crit Rev Clin Lab Sci. 2023. PMID: 37232394 Free article. Review.
Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry.
Noori S, Wijnands C, Langerhorst P, Bonifay V, Stingl C, Touzeau C, Corre J, Perrot A, Moreau P, Caillon H, Luider TM, Dejoie T, Jacobs JFM, van Duijn MM. Noori S, et al. Among authors: wijnands c. Blood Cancer J. 2023 Feb 24;13(1):30. doi: 10.1038/s41408-023-00803-z. Blood Cancer J. 2023. PMID: 36828828 Free PMC article. No abstract available.
M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibrator.
Wijnands C, Langerhorst P, Noori S, Keizer-Garritsen J, Wessels HJCT, Gloerich J, Bonifay V, Caillon H, Luider TM, van Gool AJ, Dejoie T, VanDuijn MM, Jacobs JFM. Wijnands C, et al. Clin Chem Lab Med. 2023 Oct 12;62(3):540-550. doi: 10.1515/cclm-2023-0781. Print 2024 Feb 26. Clin Chem Lab Med. 2023. PMID: 37823394 Free PMC article.
N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma.
Langerhorst P, Baerenfaenger M, Kulkarni P, Nadal S, Wijnands C, Post MA, Noori S, vanDuijn MM, Joosten I, Dejoie T, van Gool AJ, Gloerich J, Lefeber DJ, Wessels HJCT, Jacobs JFM. Langerhorst P, et al. Among authors: wijnands c. Clin Chem Lab Med. 2024 Feb 9;62(8):1626-1635. doi: 10.1515/cclm-2023-1189. Print 2024 Jul 26. Clin Chem Lab Med. 2024. PMID: 38332688 Free article.
An automated workflow based on data independent acquisition for practical and high-throughput personalized assay development and minimal residual disease monitoring in multiple myeloma patients.
Wijnands C, Armony G, Noori S, Gloerich J, Bonifay V, Caillon H, Luider TM, Brehmer S, Pfennig L, Srikumar T, Trede D, Kruppa G, Dejoie T, van Duijn MM, van Gool AJ, Jacobs JFM, Wessels HJCT. Wijnands C, et al. Clin Chem Lab Med. 2024 Jun 17;62(12):2507-2518. doi: 10.1515/cclm-2024-0306. Print 2024 Nov 26. Clin Chem Lab Med. 2024. PMID: 38872409 Free article.
Effect of alemtuzumab-based T-cell depletion on graft compositional change in vitro and immune reconstitution early after allogeneic stem cell transplantation.
Roex MCJ, Wijnands C, Veld SAJ, van Egmond E, Bogers L, Zwaginga JJ, Netelenbos T, von dem Borne PA, Veelken H, Halkes CJM, Falkenburg JHF, Jedema I. Roex MCJ, et al. Among authors: wijnands c. Cytotherapy. 2021 Jan;23(1):46-56. doi: 10.1016/j.jcyt.2020.08.003. Epub 2020 Sep 15. Cytotherapy. 2021. PMID: 32948458 Free article.
Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graft.
Loeff FC, van Egmond EHM, Moes DJAR, Wijnands C, Von Dem Borne PA, Veelken H, Falkenburg JHF, Jedema I, Halkes CJM. Loeff FC, et al. Among authors: wijnands c. Transpl Immunol. 2019 Dec;57:101209. doi: 10.1016/j.trim.2019.06.001. Epub 2019 Jun 14. Transpl Immunol. 2019. PMID: 31207283 Free article.